These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1596595)

  • 1. Pharmacological approaches to the treatment of intermittent claudication.
    Bevan EG; Waller PC; Ramsay LE
    Drugs Aging; 1992; 2(2):125-36. PubMed ID: 1596595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF; Davie AM; Clegg JP
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The limits of evidence in drug approval and availability: a case study of cilostazol and naftidrofuryl for the treatment of intermittent claudication.
    Hong H; Mackey WC
    Clin Ther; 2014 Aug; 36(8):1290-301. PubMed ID: 25012728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naftidrofuryl: a review of its use in the treatment of intermittent claudication.
    Goldsmith DR; Wellington K
    Drugs Aging; 2005; 22(11):967-77. PubMed ID: 16323973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatment options in intermittent claudication: the US experience.
    Hiatt WR
    Int J Clin Pract Suppl; 2001 Apr; (119):20-7. PubMed ID: 11355276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological management of intermittent claudication: a meta-analysis of randomised trials.
    Moher D; Pham B; Ausejo M; Saenz A; Hood S; Barber GG
    Drugs; 2000 May; 59(5):1057-70. PubMed ID: 10852639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E; Bahnini A; Mouren X; Gamand S
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
    Meng Y; Squires H; Stevens JW; Simpson E; Harnan S; Thomas S; Michaels J; Stansby G; O'Donnell ME
    Angiology; 2014 Mar; 65(3):190-7. PubMed ID: 23378195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silence of the limbs pharmacological symptomatic treatment of intermittent claudication.
    De Backer T; Vander Stichele R; De Buyzere M; De Backer G; Van Bortel L
    Curr Vasc Pharmacol; 2010 May; 8(3):383-7. PubMed ID: 19485897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug treatment of intermittent claudication.
    Jacoby D; Mohler ER
    Drugs; 2004; 64(15):1657-70. PubMed ID: 15257627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol: treatment of intermittent claudication.
    Reilly MP; Mohler ER
    Ann Pharmacother; 2001 Jan; 35(1):48-56. PubMed ID: 11197586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilostazol.
    Sorkin EM; Markham A
    Drugs Aging; 1999 Jan; 14(1):63-71; discussion 72-3. PubMed ID: 10069409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
    Prescrire Int; 2009 Apr; 18(100):56-9. PubMed ID: 19585717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC; Moher D; Barber GG
    CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
    Roset PN
    Br J Surg; 2013 Dec; 100(13):1838. PubMed ID: 24227374
    [No Abstract]   [Full Text] [Related]  

  • 16. Pentoxifylline and intermittent claudication: review of clinical trials and cost-effectiveness analyses.
    Gillings DB
    J Cardiovasc Pharmacol; 1995; 25 Suppl 2():S44-50. PubMed ID: 8699861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
    Stevens JW; Simpson E; Harnan S; Squires H; Meng Y; Thomas S; Michaels J; Stansby G
    Br J Surg; 2013 Dec; 100(13):1838-9. PubMed ID: 24227373
    [No Abstract]   [Full Text] [Related]  

  • 18. Naftidrofuryl can enhance the quality of life in patients with intermittent claudication.
    Spengel F; Brown TM; Poth J; Lehert P
    Vasa; 1999 Aug; 28(3):207-12. PubMed ID: 10483329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of intermittent claudication.
    Doggrell SA
    Expert Opin Pharmacother; 2001 Nov; 2(11):1725-36. PubMed ID: 11825312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985.
    Cameron HA; Waller PC; Ramsay LE
    Br J Clin Pharmacol; 1988 Nov; 26(5):569-76. PubMed ID: 3061424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.